VAGO, LUCA ALDO EDOARDO
 Distribuzione geografica
Continente #
EU - Europa 894
NA - Nord America 784
AS - Asia 204
OC - Oceania 9
SA - Sud America 8
AF - Africa 3
Totale 1.902
Nazione #
US - Stati Uniti d'America 774
SE - Svezia 618
IT - Italia 177
HK - Hong Kong 69
CN - Cina 55
JP - Giappone 38
FI - Finlandia 28
DE - Germania 18
IE - Irlanda 15
IN - India 11
CA - Canada 10
AU - Australia 9
GB - Regno Unito 9
SA - Arabia Saudita 9
FR - Francia 7
IR - Iran 7
SG - Singapore 7
HU - Ungheria 5
AT - Austria 4
BR - Brasile 4
CL - Cile 4
CH - Svizzera 3
IL - Israele 3
PK - Pakistan 3
DZ - Algeria 2
NL - Olanda 2
RU - Federazione Russa 2
CZ - Repubblica Ceca 1
EG - Egitto 1
ES - Italia 1
IQ - Iraq 1
LT - Lituania 1
MK - Macedonia 1
RS - Serbia 1
TH - Thailandia 1
UA - Ucraina 1
Totale 1.902
Città #
Lawrence 225
Princeton 225
Milan 70
Ashburn 60
New York 48
Shanghai 33
Helsinki 28
Dublin 15
Chaoyang 10
Tokyo 9
Washington 8
Gorgonzola 7
Rome 7
Seattle 7
Bologna 6
Los Angeles 6
Beijing 5
Borås 5
Budapest 5
Falls Church 5
Hanover 5
Jeddah 5
New Haven 5
Overland Park 5
Perth 5
Aci Sant'Antonio 4
Andover 4
Baltimore 4
Elsternwick 4
Montreal 4
Pune 4
San Jose 4
Santiago 4
Genoa 3
Ibaraki 3
Iowa City 3
Kfar Saba 3
Oberndorf bei Salzburg 3
Phoenix 3
Segrate 3
Alagappapuram 2
Bergamo 2
Boardman 2
Bordeaux 2
Castelli Calepio 2
Castelseprio 2
Central 2
Crotone 2
Des Moines 2
Edgware 2
Ekimaedori 2
Ferrara 2
Figline Valdarno 2
Florence 2
Hong Kong 2
Kolkata 2
Livorno 2
L’Aquila 2
Maple 2
Mestre 2
Muzaffargarh 2
Nanjing 2
Naples 2
Palermo 2
Paris 2
Redwood City 2
Sheffield 2
Siena 2
St Louis 2
Surat 2
São Paulo 2
Toronto 2
Turin 2
Vanzago 2
Westmont 2
Xian 2
Zurich 2
Aioicho 1
Albuquerque 1
Bangalore 1
Bangkok 1
Besana In Brianza 1
Boydton 1
Brierley Hill 1
Cambridge 1
Chicago 1
Cormano 1
Duncan 1
Essen 1
Ferentino 1
Guarulhos 1
Houston 1
Ikoma 1
Islamabad 1
Jackson 1
Liskeard 1
London 1
Mainz 1
Messina 1
Monza 1
Totale 959
Nome #
MODELING ADOPTIVE IMMUNOTHERAPY IN MOUSE-HUMANS CHIMERAS TO IDENTIFY NOVEL MECHANISMS OF LEUKEMIA IMMUNOEDITING 68
Infusion of suicide-gene-engineered donor lymphocytes after family haploidentical haemopoietic stem-cell transplantation for leukaemia (the TK007 trial): a non-randomised phase I-II study 58
Incidence, risk factors and clinical outcome of leukemia relapses with loss of the mismatched HLA after partially incompatible hematopoietic stem cell transplantation 34
QUANTITATIVE PCR-BASED CHIMERISM MONITORING IN BONE MARROW OR PERIPHERAL BLOOD TO PREDICT LEUKAEMIA RELAPSE IN HIGH-RISK PATIENTS: FINAL RESULTS OF THE KIM-PB PROSPECTIVE STUDY 32
Sirolimus-based graft-versus-host disease prophylaxis promotes the in vivo expansion of regulatory T cells and permits peripheral blood stem cell transplantation from haploidentical donors 28
CRISPR-based gene disruption and integration of high-avidity, WT1-specific T cell receptors improve antitumor T cell function 27
Allogeneic hematopoietic stem cell transplantation in patients older than 65 years with acute myeloid leukemia and myelodysplastic syndrome: a 15-year experience 26
Immunoediting of the genomic and transcriptional profile of acute myeloid leukaemia in response to allogeneic haematopoietic stem cell transplantation 24
Results from the HLA COVID-Italia study: An unexpected correlation between HLA-DP antigen load and COVID-19 severity 22
Tracking genetically engineered lymphocytes long-term reveals the dynamics of T cell immunological memory 22
Anidulafungin primary prophylaxis in 28 high-risk patients undergoing allogeneic haematopoietic stem cell transplantation: a single-centre experience 22
Azacitidine and donor lymphocytes infusions in acute myeloid leukemia and myelodysplastic syndrome relapsed after allogeneic hematopoietic stem cell transplantation from alternative donors 21
Posttransplantation Cyclophosphamide- and Sirolimus-Based Graft-Versus-Host-Disease Prophylaxis in Allogeneic Stem Cell Transplant 20
Allogeneic hematopoietic stem cell transplantation for neuromyelitis optica. 19
Immune signature drives leukemia escape and relapse after hematopoietic cell transplantation 19
Graft-versus-lymphoma effect inside the central nervous system in a patient with extranodal natural killer/T-cell lymphoma, nasal type 19
Integrated Multiomic Profiling Identifies the Epigenetic Regulator PRC2 as a Therapeutic Target to Counteract Leukemia Immune Escape and Relapse 19
Genomic Loss of Mismatched Human Leukocyte Antigen and Leukemia Immune Escape From Haploidentical Graft-Versus-Leukemia 18
PROFILING THE MUTATIONAL LANDSCAPE OF ACUTE MYELOID LEUKEMIA AT RELAPSE AFTER CHEMOTHERAPY AND ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION 18
CRISPR/CAS9-BASED GENOME EDITING TO MODEL THE ANTI-LEUKEMIA IMMUNE RESPONSE AND IDENTIFY ITS MOLECULAR PLAYERS 17
Quantitative PCR-based chimerism in bone marrow or peripheral blood to predict acute myeloid leukemia relapse in high-risk patients: results from the KIM-PB prospective study 17
Dynamics of polyclonal immuno-reconstitution after allogeneic transplant with post-transplant cyclophosphamide and letermovir 16
T Cell Suicide Gene Therapy Prompts Thymic Renewal in Adults After Haploidentical Hematopoietic Stem Cell Transplantation in the Absence of Post-Transplant Immunesuppression 16
Adjuvant role of SeptiFast to improve the diagnosis of sepsis in a large cohort of hematological patients 16
Clinical and molecular features associated with acute myeloid leukemia engraftment in immunodeficient mouse models 16
A Mechanistic Role For Mir-126, a Hematopoietic Stem Cell Microrna, In Acute Leukemias 16
Targeting WT1 reactivation in patients in complete remission after allogeneic haematopoietic stem cell transplantation for AML and MDS: results in 111 patients 16
Atypical acute myeloid leukemia-specific transcripts generate shared and immunogenic MHC class-I-associated epitopes 16
Loss of mismatched HLA in leukemia after stem-cell transplantation 15
Immune monitoring in allogeneic hematopoietic stem cell transplant recipients: a survey from the EBMT-CTIWP 15
Longitudinal qPCR monitoring of nucleophosmin 1 mutations after allogeneic hematopoietic stem cell transplantation to predict AML relapse 15
Improving the Diagnostic Algorithm for Sepsis: Adjuvant Role of SeptiFast in 491 Consecutive Hematological Patients 15
Targeting intracellular WT1 in AML with a novel RMF-peptide-MHC-specific T-cell bispecific antibody 15
Neural stem cell transplantation in patients with progressive multiple sclerosis: an open-label, phase 1 study 14
Allogeneic haematopoietic stem cell transplantation in refractory neuromyelitis optica spectrum disorders 14
Longitudinal microbiome profile associates with the risk of major transplant-related complications in allogeneic HSCT recipients 14
Cytomegalovirus-specific T cells restricted for shared and donor human leukocyte antigens differentially impact on Cytomegalovirus reactivation risk after allogeneichematopoietic stem cell transplantation 13
Early molecular diagnosis of aspergillosis in a patient with acute myeloid leukaemia 13
Genomic typing for patient-specific human leukocyte antigen-alleles is an efficient tool for relapse detection of high-risk hematopoietic malignancies after stem cell transplantation from alternative donors 13
Human Herpesvirus 6 Infection Following Haploidentical Transplantation: Immune Recovery and Outcome 13
A new tool for rapid and reliable diagnosis of HLA loss relapses after HSCT 13
NY-ESO-1 TCR single edited stem and central memory T cells to treat multiple myeloma without graft-versus-host disease 13
Facing the Rising Tide of Multidrug Resistant Gram-Negative Pathogens in Allogeneic HSCT with Nanosphere's Verigene((R)) System 13
Mechanisms of Leukemia Immune Evasion and Their Role in Relapse After Haploidentical Hematopoietic Cell Transplantation 13
Allelic HLA Matching and Pair Origin Are Favorable Prognostic Factors for Unrelated Hematopoietic Stem Cell Transplantation in Neoplastic Hematologic Diseases: An Italian Analysis by the Gruppo Italiano Trapianto di Cellule Staminali e Terapie Cellulari, Italian Bone Marrow Donor Registry, and Associazione Italiana di Immunogenetica e Biologia dei Trapianti 13
Longitudinal single-cell profiling of chemotherapy response in acute myeloid leukemia 12
Erratum: Tracking genetically engineered lymphocytes long-term reveals the dynamics of T cell immunological memory (Science Translational Medicine (2015) 7:319 (319er9)) 12
Comparative evaluation of biological HLA-DPB1 mismatch models for survival and graft versus host disease prediction after unrelated donor hematopoietic cell transplantation 12
Acute Myeloid Leukemia Relapses after Allogenenic HSCT Display a Distinctive Immune-Related Signature, with Frequent and Functionally Relevant Alterations in HLA Class II Antigen Presentation and T Cell Costimulation 12
TREOSULFAN-BASED CONDITIONING AND UNMANIPULATED PERIPHERAL BLOOD HAPLOIDENTICAL TRANSPLANTATION (HAPLOSCT) FOR PRIMARY REFRACTORY AND RELAPSED AML: RESULTS IN 63 PATIENTS 12
Improving the safety of cell therapy with the TK-suicide gene. 11
Nonpermissive HLA-DPB1 disparity is a significant independent risk factor for mortality after unrelated hematopoietic stem cell transplantation 11
Alterations in the genomic and transcriptional profile of leukemia upon the immune pressure of allogenic hematopoietic stem cell transplantation: tracking immunoediting by high-throughput techniques 11
Haploidentical HSCT: a 15-year experience at San Raffaele. 11
NK cell recovery after haploidentical HSCT with posttransplant cyclophosphamide: Dynamics and clinical implications 11
Bone marrow central memory and memory stem T-cell exhaustion in AML patients relapsing after HSCT 11
Allogeneic Hematopoietic Stem Cell Transplantation For Severe Neuromyelitis Optica 11
Antifungal Prophylaxis with Posaconazole in Allogeneic Hematopoietic Stem Cell Transplantation Using Sirolimus for Prevention of Graft-Versus-Host Disease 11
Frequency and targeted detection of HILA-DPB1 alleles encoding non-permissive transplantation antigens 11
Rapid and effective immune reconstitution with HSV-TK engineered donor lymphocyte add-backs after Haplo-HSCT 10
Genomic loss of mismatched HLA in leukemia is a major mechanism of in vivo escape from T cell immunosurveillance following haploidentical hematopoietic stem cell transplantation 10
The effect of donor-recipient KIR ligand incompatibility after haploidentical hematopoietic stem cell transplantation is overruled by biological characteristics of early reconstituting NK cells with impaired graft versus leukemia activity 10
Integrating a prospective pilot trial and patient-derived xenografts to trace metabolic changes associated with acute myeloid leukemia 10
Early and Effective Immune-Recovery by Gene-Engineered Lymphocytes after Haploidentical Transplantation for Leukemia Abate Late Transplant Mortality 10
Droplet digital polymerase chain reaction for DNMT3A and IDH1/2 mutations to improve early detection of acute myeloid leukemia relapse after allogeneic hematopoietic stem cell transplantation 10
Enteric microbiome markers as early predictors of clinical outcome in allogeneic hematopoietic stem cell transplant (allo-HSCT): results of a prospective study in adult patients 10
Significantly higher frequencies of alloreactive CD4(+) T cells responding to nonpermissive than to permissive HLA-DPB1 T-cell epitope disparities 10
Mutation at Positively Selected Positions in the Binding Site for HLA-C Shows That KIR2DL1 Is a More Refined but Less Adaptable NK Cell Receptor Than KIR2DL3 10
AN INNOVATIVE HUMANIZED MOUSE MODEL TO INVESTIGATE THE INTERPLAY BETWEEN IMMUNE SYSTEM AND ACUTE MYELOID LEUKEMIA IN ALLOGENEIC HSCT 10
Early post-allogeneic transplantation WT1 transcript positivity predicts AML relapse 10
ELDERLY PATIENTS WITH ACUTE MYELOID LEUKEMIA AND NORMAL KARYOTYPE HAVE A FAVOURABLE OUTCOME AFTER INTENSIVE THERAPEUTIC PROGRAMS 10
Loss of Mismatched HLA At Leukemia Relapse After Hematopoietic Stem Cell Transplantation Is Significantly Associated with Clinical and Immunogenetic Hallmarks of Donor-Versus-Host Alloreactivity 10
Generation of human memory stem T cells after haploidentical T-replete hematopoietic stem cell transplantation 9
Anidulafungin primary antifungal prophylaxis in 36 high-risk haematological patients undergoing haematopoietic stem cell transplantation 9
HAPLO-SCT WITH TK plus LYMPHOCYTES PRODUCE LEUKEMIA FREE SURVIVAL COMPARABLE TO UNRELATED BONE MARROW AND CORD BLOOD TRANSPLANTATION IN HIGH RISK ACUTE LEUKEMIA: 'TK007' PHASE II STUDY FINAL ANALYSIS 9
Timing and rate of success in transplant of MUD searches through BMDW: the real case of CIC-813 in 2006–2009 9
Sorafenib promotes graft-versus-leukemia activity in mice and humans through IL-15 production in FLT3-ITD-mutant leukemia cells 9
Frequency and targeted detection of HLA-DPB1 T cell epitope disparities relevant in unrelated hematopoietic stem cell transplantation 9
VORICONAZOLE PROPHYLAXIS OF INVASIVE FUNGAL INFECTION IN HAPLOIDENTICAL ALLOGENIC STEM CELL TRANSPLANTATION 9
Epidemiology and biology of relapse after stem cell transplantation 9
RETROSPECTIVE ANALYSIS OF HIGH-RISK MYELODYSPLASTIC SYNDROME AND SECONDARY ACUTE MYELOID LEUKEMIA PATIENTS TREATED WITH ALLOGENEIC TRANSPLANTATION AT SAN RAFFAELE SCIENTIFIC INSTITUTE: A SINGLE CENTER EXPERIENCE 9
T-Cell Replete Haploidentical PBSC Transplantation Using Intensified Myeloablative Conditioning, Post-Transplant Cyclophosphamide and Sirolimus 9
T CELL ORIGIN OF CYTOKINE INDUCED KILLER CELLS 9
LONG-TERM DISEASE CONTROL OF REFRACTORY NEUROMYELITIS OPTICA AFTER ALLOGENEIC HEMATOPOIETIC STEM CELL TRANSPLANTATION 9
Monitoring for virus-specific T-cell responses and viremia in allogeneic HSCT recipients: a survey from the EBMT Cellular Therapy & Immunobiology Working Party 8
Human herpesvirus 6-specific T-cell immunity in allogeneic hematopoietic stem cell transplant recipients 8
Epitope-specific typing (EST) for HLA-DPB1 matching: Proof of principle for an innovative approach to unrelated hematopoietic stem cell donor selection. 8
Experts' considerations on HLA-haploidentical stem cell transplantation 8
Post-transplantation Cyclophosphamide and Sirolimus after Haploidentical Hematopoietic Stem Cell Transplantation Using a Treosulfan-based Myeloablative Conditioning and Peripheral Blood Stem Cells 8
TK007 phase II study final analysis. Genetically modified donor lymphocytes abate transplant related mortality and increase leukaemia-free survival providing early immune reconstitution after haploidentical haematopoietic stem cell transplantation 8
The impact of amino acid variability on alloreactivity defines a functional distance predictive of permissive HLA-DPB1 mismatches in hematopoietic stem cell transplantation 8
Temporal, quantitative and functional characteristics of Single-KIR positive alloreactive NK cell recovery account for impaired graft versus leukemia activity after haploidentical HSCT 8
Beneficial role of CD8+ T-cell reconstitution after HLA-haploidentical stem cell transplantation for high-risk acute leukaemias: results from a clinico-biological EBMT registry study mostly in the T-cell-depleted setting 8
Loss of Mismatched HLA as a Mechanism of Leukemia Immune Escape in Family Haploidentical and Unrelated HSCT: Analysis of 103 Transplants From Alternative Donors 8
An Accelerated CD8+, but Not CD4+, T -Cell Reconstitution Associates with a More Favorable Outcome Following HLA-Haploidentical HSCT: Results from a Retrospective Study of the Cell Therapy and Immunobiology Working Party of the EBMT 8
Quantitative PCR for ins/del polymorphisms is a reliable and sensitive tool for host chimerism analysis after allogeneic hematopoietic stem cell transplantation 8
Clonal evolution and immune evasion in posttransplantation relapses 8
Cytokine-induced killer cells are terminally differentiated activated CD8 cytotoxic T-EMRA lymphocytes 8
Kinetics of acute and chronic GvHD control by ganciclovir in-vivo HSV-TK suicide gene activation: long-term GvHD-free survival in 57 patients after haploidentical TK-cells 8
CYTOKINE INDUCED KILLER CELLS: IN VITRO DIFFERENTIATED T CELLS WITH ANTI-TUMORAL ACTIVITY 8
Totale 1.421
Categoria #
all - tutte 37.677
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 37.677


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/202017 15 0 0 2 0 0 0 0 0 0 0 0
2020/2021142 0 0 0 6 2 1 126 2 5 0 0 0
2021/2022144 0 0 0 34 12 8 6 21 22 18 10 13
2022/20231.263 493 293 82 10 43 136 38 79 49 14 17 9
2023/2024517 32 29 61 66 44 87 106 56 12 23 1 0
Totale 2.128